Ranch Capital Advisors Inc. Invests $438,000 in Stryker Corporation (NYSE:SYK)

Key Points

• Ranch Capital Advisors Inc. acquired a new stake of 1,175 shares in Stryker Corporation, valued at approximately $438,000, indicating increasing institutional interest in the company.
• Stryker reported $3.13 EPS for the latest quarter, surpassing analysts' expectations, and achieved revenue growth of 11.1% year-over-year.
• The company declared a quarterly dividend of $0.84 per share, with a current yield of 0.9% and a payout ratio of 44.50%.

Ranch Capital Advisors Inc. bought a new stake in Stryker Corporation (NYSE:SYK - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,175 shares of the medical technology company's stock, valued at approximately $438,000.

Several other large investors also recently bought and sold shares of SYK. Capital A Wealth Management LLC acquired a new stake in Stryker during the fourth quarter worth approximately $26,000. Goodman Advisory Group LLC acquired a new stake in Stryker during the 1st quarter worth $32,000. City Holding Co. lifted its position in Stryker by 528.6% in the first quarter. City Holding Co. now owns 88 shares of the medical technology company's stock valued at $33,000 after acquiring an additional 74 shares during the last quarter. Smallwood Wealth Investment Management LLC acquired a new position in Stryker in the first quarter valued at $40,000. Finally, Itau Unibanco Holding S.A. purchased a new position in shares of Stryker during the fourth quarter worth about $42,000. Hedge funds and other institutional investors own 77.09% of the company's stock.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 200,000 shares of the business's stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the sale, the director owned 3,222,108 shares of the company's stock, valued at approximately $1,212,962,556.60. The trade was a 5.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 5.90% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Needham & Company LLC boosted their target price on Stryker from $442.00 to $448.00 and gave the company a "buy" rating in a report on Friday, August 1st. JMP Securities reiterated a "market perform" rating on shares of Stryker in a research note on Monday, May 5th. Evercore ISI increased their price objective on Stryker from $390.00 to $415.00 and gave the company an "outperform" rating in a report on Tuesday, July 8th. Wall Street Zen raised shares of Stryker from a "hold" rating to a "buy" rating in a report on Friday, July 18th. Finally, Sanford C. Bernstein set a $450.00 price target on shares of Stryker in a research report on Monday, May 5th. Four equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $430.10.

Stryker Stock Performance

SYK traded up $1.27 during trading on Thursday, reaching $376.21. The company's stock had a trading volume of 1,192,081 shares, compared to its average volume of 1,331,951. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. The company's fifty day moving average price is $387.27 and its 200-day moving average price is $380.27. Stryker Corporation has a 52-week low of $320.78 and a 52-week high of $406.19. The company has a market capitalization of $143.83 billion, a price-to-earnings ratio of 49.83, a price-to-earnings-growth ratio of 2.72 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, beating analysts' consensus estimates of $3.07 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%. The firm had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $5.92 billion. During the same period in the previous year, the business earned $2.81 earnings per share. The company's revenue for the quarter was up 11.1% compared to the same quarter last year. On average, equities analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. Stryker's dividend payout ratio (DPR) is 44.50%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.